Search for: "Sandoz GmbH" Results 21 - 40 of 68
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Feb 2019, 3:45 am by Bart van Wezenbeek
Bart van WezenbeekRelevant prior art may prove not to be useful as a starting point for an attack on inventive step if the prior art teaching is negated by later studies before the effective date of the patent claims. [read post]
23 Feb 2011, 9:51 am by Steve Hall
The drug was made by Sandoz GmbH, an Austrian company, according to the Justice and Public Safety Cabinet. [read post]
23 Nov 2015, 2:40 pm
 ****************** PREVIOUSLY, ON NEVER TOO LATE Never Too Late 72 [week ending on Sunday 15 November] –  Merck Sharp & Dohme v Ono Pharmaceutical | Warner-Lambert Co LLC v Sandoz GmbH, Sandoz Ltd and Lloyds Pharmcacy Ltd | Economics of internet trolls | UK IPO scammer scammed | Video conferencing at the EPO | Warner-Lambert v Pfizer in France | African Ministerial Conference in IP | Green claims and… [read post]
7 Dec 2015, 12:56 pm
**********PREVIOUSLY, ON NEVER TOO LATENever Too Late 74 [week ending on Sunday 29 November] –  Bob Marley copyright | Nintendo TPM triumphs in Italy | GIs and TMs in the EU | Prebalin again | YouTube will defend fair use | End-of-year reading |Stretchline Intellectual Properties Ltd v H&M Hennes & Mauritz UK Ltd | Goodbye from Jeremy, and thank you from us | Greekat on plain packaging | Rovi Guides Inc v Virgin Media Ltd & Others | IP… [read post]
9 Dec 2015, 7:12 am
Rolls Building In Swiss Style Claims: Warner-Lambert Companv Actavis 25 Jan 2015 I explained that Warner-Lambert LLC had a patent for a drug called pregabalin for treating epilepsy and GAD (generalized anxiety disorder). [read post]
5 May 2010, 4:46 am
SmithKline Beecham plc & Anor v Sandoz AG & Anor (Afro-IP) Cenestin (conjugated estrogens)– US: Patent infringement suit in response to Para IV challenge: Teva Women's Health, Inc. v. [read post]
9 Apr 2009, 7:52 am
(Part I - Patent Circle) (Part II – Patent Circle) Indian biogenerics on an upswing – US Promoting Innovation and Access to Life-Saving Medicine Act (Patent Baristas) US: Anti-reverse payment legislation Protecting Consumer Access to Generic Drugs Act of 2009 introduced in the House (Patent Docs) US: CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent… [read post]
25 Feb 2011, 8:02 am by Steve Hall
The packaging indicated the drug was made by Sandoz International GmbH, a European generics company, Kentucky Justice and Public Safety Cabinet spokeswoman Jennifer Brislin said. [read post]
27 Sep 2016, 9:10 am
Panellists from Pfizer, Sandoz GmbH and Taiwan's National Yunlin University debated the global regulatory, substitution and interchangeability issues affecting biosimilars, before giving an overview of relevant patent litigation strategies. [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
22 Sep 2016, 5:32 pm
Vanessa reports:"In the second Pharma session on Monday, Moderator Dominic Adair (Bristows, UK) and panellists Fritz Reiter, (Regulatory CMC Team Leader, Sandoz GmbH, AT), Prof. [read post]
13 Dec 2015, 4:01 pm
**********PREVIOUSLY, ON NEVER TOO LATENever too late 75 [week ending on Sunday 6 December] –  BHG on blocking injunctions | IP in Universities | Sweden on blocking injunctions | Canadian musings on patents | US Senate and trade secret reform | Chinese IP Courts | G1/14 referral and Article 108 EPC | PACE procedure (Procedure for Accelerated Conduct of Examination) ant the EPO | Greekat and trade mark partenalism | EPO Boards of Appeal tell AC: we were… [read post]
11 Sep 2018, 7:05 am by Lawrence B. Ebert
Sandoz, Inc., 544 F.3d1341, 1352 (Fed. [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation (IP Law Observer) Lescol (Fluvastatin) - US: Mylan confirms first-to-file patent challenge to Lescol by Novartis (SmartBrief) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd & Anor (IPKat)… [read post]